UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001576
Receipt number R000001899
Scientific Title A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease
Date of disclosure of the study information 2008/12/17
Last modified on 2011/08/02 13:02:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease

Acronym

The efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of Parkinson's disease.

Scientific Title

A randomized, double-blind, placebo- controlled, multi-center, parallel study concerning the efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of motor and non- motor symptoms in Parkinson's disease

Scientific Title:Acronym

The efficacy of repetitive transcranial magnetic stimulation over the supplementary motor area in treatment of Parkinson's disease.

Region

Japan


Condition

Condition

Parkinson's disease

Classification by specialty

Neurology Neurosurgery Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate efficacy and safety of repetitive transcranial magnetic stimulation over the supplementary motor area for Parkinson's disease

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

Unified Parkinson's Disease Rating Scale(UPDRS) part 3

Key secondary outcomes

UPDRS part 1,2,4, 5-point scale for daily life and tremor, Apathy scale, 17 item of Hamilton depression scale, Non-Motor Symptoms Questionnaire


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

Repetitive transcranial magnetic stimulation over the supplementary motor area, high-frequency stimulation

Interventions/Control_2

Repetitive transcranial magnetic stimulation over the supplementary motor area, low-frequency stimulation

Interventions/Control_3

Sham stimulation

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1)Diagnosed as Parkinson's disease (PD) according to the UK Parkinson's disease Society brain bank 2) Patients who are capable of ambulatory hospital visits 3)Patients who consented to keep drug and living conditions during the study. 4)Patients who were rated as Hoehn-Yahr grade 2 or 3 or 4. 5) Those who give us informed consent to participate in the present study after detailed explanation of the study

Key exclusion criteria

1)The patients who underwent the TMS treatment before 2)No implantation of metal in head, except in the mouth 3) Those having heart pacemaker or drug infusion pomp 4) Serious heart disease 5)History of massive cerebral infarction, head injury, brain tumor, or epilepsy 6)Pregnant or intend to be pregnant

Target sample size

150


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshikazu Ugawa

Organization

Fukushima medical university

Division name

Department of neurology

Zip code


Address

1, Hikarigaoka, Fukushima, 960-1295, Japan

TEL

024-547-1246

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hiroyuki Enomoto

Organization

Fukushima medical university

Division name

Department of neurology

Zip code


Address

1, Hikarigaoka, Fukushima, 960-1295, Japan

TEL

024-547-1248

Homepage URL


Email



Sponsor or person

Institute

Department of neurology, Fukushima medical university

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labor and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Univ: Occupational Environ Health,Tokushima,Kyusyu,Tottori,Tokyo,Hokkaido,Saitama Med,Osaka, Hamamatsu Med,Kinki)
Tokyo neurological hos,Kumamoto Kinoh hos, Nagasaki Med center of Neurol

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 12 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2008 Year 11 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2008 Year 12 Month 15 Day

Last modified on

2011 Year 08 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001899


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name